Research Infrastructure Core
研究基础设施核心
基本信息
- 批准号:10271284
- 负责人:
- 金额:$ 60.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-30 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimalsApplications GrantsAreaAwardBioinformaticsBiological ProductsBiomedical ResearchBiometryClinical SciencesCollaborationsCore FacilityDevelopmentEducational workshopEnvironmentEquipmentEvaluationEventFacultyFeesFormulationFundingGrantHealth care facilityHuman ResourcesInfrastructureInstitutionInterdisciplinary StudyInternationalInterventionLaboratoriesLeadLegal patentLinkMethionineMethodologyMolecularMolecular BiologyMolecular and Cellular BiologyPeer ReviewPeptide HydrolasesPharmacologyPharmacy facilityPilot ProjectsProductivityPublishingReproducibilityResearchResearch DesignResearch InfrastructureResearch InstituteResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesReverse Transcriptase Polymerase Chain ReactionServicesStructureTechniquesTexasToxic effectTrainingTraining ProgramsTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWorkanimal careantimicrobial drugcancer preventioncareercastration resistant prostate cancerchemotherapeutic agentcommunity engagementdata managementdrug candidatedrug developmentdrug metabolismenvironmental toxicologyfaculty researchfallsgenetic analysisgenome editinggulf coastimprovedinnovationinstrumentlead optimizationmemberminority healthnew therapeutic targetnovelpharmacokinetics and pharmacodynamicspre-clinicalpreclinical developmentprogramsrecruitskillssymposiumsynergismweb site
项目摘要
Abstract
Texas Southern University (TSU), the nation’s second largest HBCU, has been continuously supported by the
RCMI program for many years, and has significantly strengthened our research environment. In the last RCMI
funding cycle, we successfully developed and deployed three core facilities including Pharmacology, Molecular
Biology, and Environmental Toxicity. These advances have led to productive collaborations on projects including
new drug targets, new lead compounds, preclinical lead optimization, and formulation. However, there is an
unmet need to enhance our research resources and services to include study design, methodology development,
data management, specialized laboratory techniques (e.g., genome editing, animal work skills), instrument
utilization, and collaboration networks. In this renewal application, we propose to establish a Research
Infrastructure Core (RIC) in the Center for Biomedical and Minority Health Research (CBMHR) to support
research and pilot projects by providing these enhanced services (in addition to research infrastructure made
available through previous RCMI funding) to TSU and external users and to facilitate new collaborations in
biomedical research. The specific aims are: Support CBMHR research and pilot projects and provide services
to users to enhance quality and productivity of biomedical research (Aim 1); Develop and validate laboratory
techniques to support CBMHR research and pilot projects and provide trainings to internal and external users
(Aim 2); and Facilitate networking to increase collaborative research projects and grant applications (Aim 3).
We propose to form a faculty expert team, consultant team, and recruit skilled staff to support our users in six
areas in which we have great expertise and credibility. The involved personnel, including core director, co-
director, faculty expert team members, and consultants, will be experts in the key research areas. We also
propose to facilitate new collaborations with experts in other institutions to integrate research resources across
the Houston area. Additionally, we will integrate core information including fee structures into the CBMHR
website to promote our services. Innovations of this proposed RIC include novel research methodology
development, collaborative research projects and grant applications, and collaborative synergism. We expect
that this proposed RIC will significantly enhance TSU’s research capability in biomedical and minority health
research so that more competitive grant proposals can be submitted to different agencies (e.g., NIH) and more
faculty, especially junior faculty, will be successful in their academic career.
摘要
德州南方大学(大津),全国第二大HBCU,一直支持由
RCMI计划多年来,并大大加强了我们的研究环境。在上一届RCMI中,
在资金周期内,我们成功开发和部署了三个核心设施,包括药理学,分子生物学,
生物学和环境毒性。这些进步导致了项目上的富有成效的合作,包括
新的药物靶点、新的先导化合物、临床前先导化合物优化和配方。然而,有一个
未满足的需求,以加强我们的研究资源和服务,包括研究设计,方法开发,
数据管理,专门的实验室技术(例如,基因组编辑,动物工作技能),仪器
利用和协作网络。在这次更新申请中,我们建议建立一个研究
生物医学和少数民族健康研究中心(CBMHR)的基础设施核心(RIC),
研究和试点项目,提供这些增强的服务(除了研究基础设施,
通过以前的RCMI资金提供),以大津和外部用户,并促进新的合作,
生物医学研究具体目标是:支持CBMHR研究和试点项目,并提供服务
提高生物医学研究的质量和生产力(目标1);开发和验证实验室
支持CBMHR研究和试点项目的技术,并为内部和外部用户提供培训
(Aim促进联网,以增加合作研究项目和赠款申请(目标3)。
我们建议成立一个教师专家团队,顾问团队,并招募熟练的工作人员,以支持我们的用户在六个
我们在这些领域拥有丰富的专业知识和信誉。参与的人员,包括核心董事,联席董事,
主任、教员专家小组成员和顾问将是重点研究领域的专家。我们也
建议促进与其他机构的专家进行新的合作,以整合各机构的研究资源。
休斯顿地区。此外,我们将把包括费用结构在内的核心信息整合到CBMHR中
网站来推广我们的服务。该RIC的创新包括新颖的研究方法
开发、合作研究项目和赠款申请以及协作增效。我们预计
这个拟议的RIC将大大提高大津在生物医学和少数民族健康方面的研究能力
研究,以便更有竞争力的赠款提案可以提交给不同的机构(例如,NIH)和更多
教师,特别是初级教师,将在他们的学术生涯中取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Song Gao其他文献
Song Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Song Gao', 18)}}的其他基金
Selectively Manipulating Intestinal Glucuronidation to Alleviate Mycophenolate mofetil-induced Diarrhea
选择性操纵肠道葡萄糖醛酸化以减轻吗替麦考酚酯引起的腹泻
- 批准号:
10628498 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Developing Recycled Colon Bioavailable (r-CB) COXIBs for the Treatment of Familial adenomatous polyposis (FAP)
开发回收结肠生物可利用 (r-CB) COXIB 用于治疗家族性腺瘤性息肉病 (FAP)
- 批准号:
9233309 - 财政年份:2017
- 资助金额:
$ 60.46万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 60.46万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 60.46万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 60.46万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 60.46万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 60.46万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




